"Fibronectins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glycoproteins found on the surfaces of cells, particularly in fibrillar structures. The proteins are lost or reduced when these cells undergo viral or chemical transformation. They are highly susceptible to proteolysis and are substrates for activated blood coagulation factor VIII. The forms present in plasma are called cold-insoluble globulins.
| Descriptor ID |
D005353
|
| MeSH Number(s) |
D12.776.377.715.390 D12.776.395.550.350 D12.776.543.550.350 D12.776.860.300.450
|
| Concept/Terms |
Fibronectins- Fibronectins
- Opsonic alpha(2)SB Glycoprotein
- Opsonic Glycoprotein
- Glycoprotein, Opsonic
- LETS Proteins
- Proteins, LETS
- alpha 2-Surface Binding Glycoprotein
- alpha 2 Surface Binding Glycoprotein
- Fibronectin
- Cold-Insoluble Globulins
- Cold Insoluble Globulins
- Globulins, Cold-Insoluble
|
Below are MeSH descriptors whose meaning is more general than "Fibronectins".
Below are MeSH descriptors whose meaning is more specific than "Fibronectins".
This graph shows the total number of publications written about "Fibronectins" by people in this website by year, and whether "Fibronectins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 3 | 2 | 5 |
| 1995 | 5 | 4 | 9 |
| 1996 | 3 | 4 | 7 |
| 1997 | 0 | 1 | 1 |
| 1998 | 2 | 1 | 3 |
| 1999 | 1 | 7 | 8 |
| 2000 | 0 | 3 | 3 |
| 2001 | 1 | 2 | 3 |
| 2002 | 2 | 5 | 7 |
| 2003 | 2 | 5 | 7 |
| 2004 | 7 | 0 | 7 |
| 2005 | 2 | 3 | 5 |
| 2006 | 2 | 4 | 6 |
| 2007 | 2 | 3 | 5 |
| 2008 | 2 | 5 | 7 |
| 2009 | 1 | 2 | 3 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 2 | 2 |
| 2012 | 0 | 4 | 4 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 2 | 3 |
| 2015 | 0 | 3 | 3 |
| 2016 | 2 | 0 | 2 |
| 2017 | 2 | 2 | 4 |
| 2018 | 0 | 1 | 1 |
| 2019 | 3 | 1 | 4 |
| 2020 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
| 2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fibronectins" by people in Profiles.
-
Irisin ameliorates diabetic kidney disease by restoring autophagy in podocytes. FASEB J. 2023 10; 37(10):e23175.
-
Fibronectin Contributes to a BRAF Inhibitor-driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2. Mol Cancer Res. 2023 09 01; 21(9):867-880.
-
Irisin: A Promising Target for Ischemia-Reperfusion Injury Therapy. Oxid Med Cell Longev. 2021; 2021:5391706.
-
Antitumor Effects of CAR T Cells Redirected to the EDB Splice Variant of Fibronectin. Cancer Immunol Res. 2021 03; 9(3):279-290.
-
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer. Nat Commun. 2020 05 15; 11(1):2416.
-
Extracellular matrix-derived peptides in tissue remodeling and fibrosis. Matrix Biol. 2020 09; 91-92:176-187.
-
The microbiological characteristics of Staphylococcus aureus isolated from patients with native valve infective endocarditis. Virulence. 2019 12; 10(1):948-956.
-
Circular RNA CircFndc3b modulates cardiac repair after myocardial infarction via FUS/VEGF-A axis. Nat Commun. 2019 09 20; 10(1):4317.
-
Effect of Dose and Selection of Two Different Ligands on the Deposition and Antitumor Efficacy of Targeted Nanoparticles in Brain Tumors. Mol Pharm. 2019 10 07; 16(10):4352-4360.
-
Distinct Binding Interactions of a5?1-Integrin and Proteoglycans with Fibronectin. Biophys J. 2019 08 20; 117(4):688-695.